Within the past year we have seen 9 cases of acute hemolytic anemia in the course of sulfanilamide or sulfapyridine therapy, with 6 deaths. In the hope of explaining the mechanism of this hemolysis, the laboratory studies which form the basis of this report were conducted in 4 cases.